NCLT admits insolvency proceedings against Shilpa Medicare’s wholly owned FTF Pharma unit
As filed · Shilpa Medicare Limited has informed the Exchange about Action(s) initiated or orders passed
What happened
FactThe NCLT Ahmedabad Bench admitted an insolvency application against wholly owned subsidiary FTF Pharma Private Limited and commenced its Corporate Insolvency Resolution Process from 9 September 2026. The case concerns an alleged operational debt of ₹2,18,03,319 claimed by Immacule Lifesciences; the tribunal also imposed a moratorium and appointed Sunil Kumar Kedia as interim resolution professional.
Why it matters
CapitSignal interpretationOnce an insolvency process is admitted, control of the company passes from the board to a resolution professional and equity ranks last in any recovery.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
DelayedWe will try to monetize all these investments.
We should be doing another about INR75 crores to INR100 crores from here on.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Admission or rejection of the application by the tribunal
- Appointment of a resolution professional
- Claims admitted against the company
- So we are expecting to start our clinical study, Phase III clinical study, in Q4 FY '26. (management committed by Q4 FY26)
- We should be doing another about INR75 crores to INR100 crores from here on. (management committed by FY26)
Evidence
- Shilpa Medicare Limited has informed the Exchange about Action(s) initiated or orders passed(opens the original filing in a new tab)
- Earlier statement · Q2 FY26
- Latest statement · Q2 FY26
- Earlier statement · Q2 FY26
How CapitSignal classified this
- Reasoning:
- FTF Pharma will operate under the IBC resolution process and moratorium, which may affect the subsidiary’s financial and operational activities. Shilpa Medicare said any impact on the listed entity is not presently ascertainable or quantifiable.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%